Concerns Over Data Privacy in Menstrual Tracking Apps
Academics from the University of Cambridge have raised significant concerns regarding the collection and potential commercialization of personal information through menstrual tracking applications. A recent report from the Minderoo Centre for Technology and Democracy highlights the risks and harms associated with these popular apps, which have seen global downloads exceeding 250 million for the top three platforms.
The researchers emphasize that menstrual data can yield valuable insights into individuals’ health and reproductive choices. These applications often gather extensive information, including details about exercise, diet, medication, sexual preferences, hormone levels, and contraception use. According to the report, this data can be likened to a “gold mine” for consumer profiling, particularly as many women turn to these apps while trying to conceive, resulting in notable changes in their shopping behaviors.
“Data on who is pregnant, and who wants to be, has therefore emerged as some of the most sought-after information in digital advertising,” the authors noted, underscoring the lucrative nature of cycle tracking apps (CTAs). The report warns that the data collected is not only commercially valuable but is often shared with a complex network of third parties, making sensitive user information vulnerable to exploitation for targeted advertising.
Moreover, the researchers caution that if this data falls into the wrong hands, it could lead to serious consequences, including health insurance discrimination, risks to employment opportunities, or even domestic abuse. They advocate for enhanced governance within the “femtech” industry, calling for improved data security measures and the implementation of meaningful consent options for users.
Dr. Stefanie Felsberger, the lead author of the report, remarked, “Menstrual cycle tracking apps are presented as empowering women and addressing the gender health gap. Yet, the business model behind their services rests on commercial use, selling user data and insights to third parties for profit.”
Professor Gina Neff, executive director of the Minderoo Centre, echoed these sentiments, stating, “The use of cycle tracking apps is at an all-time high. Women deserve better than to have their menstrual tracking data treated as consumer data, but there is a different possible future.”
The research team urges public health organizations to develop alternatives to commercial tracking apps, aiming to prioritize user privacy and safety in the rapidly evolving landscape of menstrual health technology.